Inventor · disambiguated record
Anne-Sophie Rebstock
Also filed as: REBSTOCK ANNE-SOPHIE · REBSTOCK ANNE-SOPHIE HELENE MARIE
25 granted patents·21 pending applications·81 citations·filing 2006–2024
94Inventor score
Top patents by PatentIndex Score
46 records- 0195US11478554B2Antibody drug conjugates (ADCS) having enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Oct 25, 2022·5 cites·20 claims
- 0294US10973923B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2016·Granted Apr 13, 2021·8 cites·37 claims
- 0392US11643469B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2022·Granted May 9, 2023·1 cites·15 claims
- 0492US11123439B2Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groupsBayer Pharma AG·Filed 2016·Granted Sep 21, 2021·8 cites·51 claims
- 0592US10744205B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodiesBayer Pharma AG·Filed 2016·Granted Aug 18, 2020·9 cites·28 claims
- 0691US11660351B2Antibody drug conjugates (ADCs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted May 30, 2023·5 cites·50 claims
- 0790US11001636B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2017·Granted May 11, 2021·5 cites·15 claims
- 0889US11071788B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBayer Pharma AG·Filed 2016·Granted Jul 27, 2021·6 cites·32 claims
- 0989US10485880B2Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodiesBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·11 cites·29 claims
- 1087US11685714B2Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted Jun 27, 2023·3 cites·30 claims
- 1187US9090600B2Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4H)-one derivativesBRAUN CHRISTOPH·Filed 2012·Granted Jul 28, 2015·6 cites·21 claims
- 1285US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 1381US2023399411A1Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodiesBayer Pharma AG·Filed 2023·Application pending·0 cites
- 1480US2025099600A1Active Metabolites of Kinesin Spindle Protein Inhibitor ConjugatesBayer Pharma AG·Filed 2024·Application pending·0 cites
- 1576US9375010B2Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-oxadiazolone derivativesBAYER CROPSCIENCE AG·Filed 2014·Granted Jun 28, 2016·3 cites·20 claims
- 1675US2023338559A1Antibody drug conjugates (adcs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2023·Application pending·0 cites
- 1774US10519154B27-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereofBayer Pharma AG·Filed 2017·Granted Dec 31, 2019·2 cites·14 claims
- 1873US12059472B2Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBAYER AG·Filed 2017·Granted Aug 13, 2024·1 cites·15 claims
- 1971US2021230284A1Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodiesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 2070US2024043379A1Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBayer Pharma AG·Filed 2023·Application pending·0 cites
- 2168US12144865B2Antibody drug conjugates with enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Nov 19, 2024·0 cites·33 claims
- 2267US9326515B2Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2H)-one derivativesBRAUN CHRISTOPH·Filed 2012·Granted May 3, 2016·1 cites·22 claims
- 2365US2022362392A1Specific antibody drug conjugates (adcs) having ksp inhibitorsBayer Pharma AG·Filed 2022·Application pending·0 cites
- 2464US11806404B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2021·Granted Nov 7, 2023·0 cites·18 claims
- 2561US11433140B2Specific antibody drug conjugates (ADCs) having KSP inhibitorsBayer Pharma AG·Filed 2017·Granted Sep 6, 2022·0 cites·9 claims
- 2660US12501900B2Heterocyclyl pyridazine as fungicidal compoundsBAYER AG·Filed 2019·Granted Dec 23, 2025·0 cites·12 claims
- 2759US2024423973A1Compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disordersVINCERX PHARMA GMBH·Filed 2022·Application pending·0 cites
- 2858US2025032477A1Compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disordersVINCERX PHARMA GMBH·Filed 2022·Application pending·0 cites
- 2956US2024408222A1Compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorderVINCERX PHARMA GMBH·Filed 2022·Application pending·0 cites
- 3052US2016016944A1Fungicidal 3--heterocycle derivativesBAYER CROPSCIENCE AG·Filed 2014·Application pending·0 cites
- 3151US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
- 3249US9212152B2Process for the preparation of N-hydroxy-1-(1-alkyl-1H-tetrazol-5-yl)-1-phenylmethanimine derivativesCOQUERON PIERRE-YVES·Filed 2013·Granted Dec 15, 2015·0 cites·7 claims
- 3345US9743665B2Fungicidal 3-{phenyl[heterocyclylmethoxy)imino]methyl}-oxadiazolone derivativesBAYER CROPSCIENCE AG·Filed 2014·Granted Aug 29, 2017·0 cites·10 claims
- 3444US9556158B2Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2H)-one derivativesBAYER IP GMBH·Filed 2012·Granted Jan 31, 2017·0 cites·24 claims
- 3544US2016002217A1Fungicidal 3--oxadiazolone derivativesBAYER CROPSCIENCE AG·Filed 2014·Application pending·0 cites
- 3643US12414565B2Pyridazine (THIO)amides as fungicidal compoundsBAYER AG·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 3743US2013289077A1Fungicide hydroximoyl-tetrazole derivativesBENTING JUERGEN·Filed 2011·Application pending·0 cites
- 3842US2022144815A11,3,4-oxadiazoles and their derivatives as new antifungal agentsBAYER AG·Filed 2019·Application pending·0 cites
- 3942US2009221559A1Benzodiazepines as hcv inhibitorsBONFANTI JEAN-FRANCOIS·Filed 2006·Application pending·0 cites
- 4042US2021009575A1Hydroxyisoxazolines and derivatives thereofBAYER AG·Filed 2019·Application pending·0 cites
- 4141US11266147B2Fungicidal oxadiazolesBAYER AG·Filed 2018·Granted Mar 8, 2022·0 cites·20 claims
- 4239US2021147371A1Oxadiazoline derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 4339US2018318438A1Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-tweakr-antibodiesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 4438US2014051575A1Fungicide hydroximoyl-tetrazole derivativesBENTING JUERGEN·Filed 2012·Application pending·0 cites
- 4538US2021009541A1Fungicidal oxadiazolesBAYER AG·Filed 2019·Application pending·0 cites
- 4636US2018185510A1Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-b7h3-antibodiesBayer Pharma AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anne-Sophie Rebstock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →